Region: Kuwait
Category: Drug Development
Category: Drug Development
Kuwait Drug Development
(2 reports matching your criteria)
-
Global & Kuwait Cancer Therapeutics Market to 2031
... 20.5% of all diagnosed cancers. The five-year prevalence rate for breast cancer across all age groups stood at 211.30 per 100,000 people. It was also the leading cause of cancer-related deaths among women in Kuwait, ... Read More
-
Middle East and Africa Digital Pathology Market, By Product (Scanners, Software, Storage, Communication Systems, Others); By Type (Human Pathology, Veterinary Pathology); By Application (Drug Discovery, Disease Diagnosis, Training & Education); By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, Academic & Research Institutes); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Biotechnology Companies, Hospitals & Reference Laboratories, Academic & Research Institutes); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Middle East and Africa ... Read More
Research Assistance
